4492 Genetec
- 630
- -5-0.79%
Genetec News
Genetec Technology Berhad (KLSE:GENETEC) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Genetec Retains World Leader Position in Video Management Software, Analysts Confirm
Investing in Genetec Technology Berhad (KLSE:GENETEC) Five Years Ago Would Have Delivered You a 838% Gain
Genetec Helps Communities Boost Crime Prevention Initiatives With Introduction of New Collaborative Intelligence Feature for AutoVu Cloudrunner
Genetec To Go Ex-Dividend On September 27th, 2024 With 8 JPY Dividend Per Share
September 26th (Japan Standard Time) - $Genetec(4492.JP)$ is trading ex-dividend on September 27th, 2024.Shareholders of record on September 30th, 2024 will receive 8 JPY dividend per share. The ex-
Ouster Gemini Launches Genetec Security Center Integration
Insider Moves: Ocean Vantage Holdings Bhd, Yong Tai Bhd, Omesti Bhd, Hong Leong Financial Group Bhd, Genetec Technology Bhd
Genetec Unveils Cloudlink 110, a Compact Cloud-managed Video Bridge for Low-density Deployments
Genetec Expands Security Center SaaS With the Launch of Operations Center, the Industry's First Work Management Solution for Physical Security Operations
Some Genetec Technology Berhad (KLSE:GENETEC) Analysts Just Made A Major Cut To Next Year's Estimates
Order Deferment Hiccup For Genetec
Genetec Replies Bursa UMA Inquiry After Share Price Drop
Genetec Shares Plunge to July 2021 Low, Nine-day Sell-down Wipes Out RM614m Value
Genetec Updates FICAM Certification and Expands List of Access Control Options for US Federal Market
Zennetek - 1Q revenue growth of double digits, all segments are performing well and profits at all stages are in the black.
On the 9th, Zenetec <4492> announced its consolidated financial results for the first quarter of the fiscal year ending March 2025 (April-June 24), with revenue of 2.014 billion yen, an increase of 40.0% from the same period last year, an operating profit of 0.157 billion yen (a loss of 0.017 billion yen in the same period last year), an ordinary profit of 0.149 billion yen (a loss of 0.02 billion yen in the same period last year), and a net profit for the quarter attributable to the parent company's shareholders of 0.052 billion yen (a loss of 0.019 billion yen in the same period last year). The sales of the system solution business increased 31.4% year-on-year to 1.17 billion yen.
Stocks that moved the day before Part 1 include Kimura Koki, Trend Micro, Fujikura, etc.
DIC <4631> upwardly revised financial estimates for fiscal year ending March 2025 to 2.853 billion yen. Komatsu <6231> operating profit for Q1 increased by 30.7% to 4.605 billion yen. Zenetec <4492> operating profit for Q1 turned from a red figure of 0.017 billion yen in the same period of the previous year to black figure of 0.157 billion yen. Janome <6445> operating profit for Q1 turned from a red figure of 0.18 billion yen in the same period of the previous year to black figure of 0.481 billion yen. Also announced an increase in dividends. Matsuya.
Active and newly established stocks in the afternoon session.
*DIC<4631> 2853 +131.5 revised upward financial estimates for the fiscal year ending in December. *Kimura Machinery<6231> 4605 +700 operating profit increased by 30.7% in Q1. *ZENETEC<4492> 644 +100 Q1 operating profit turned from a loss of 0.017 billion yen in the same period last year to a profit of 0.157 billion yen. *Janome<6445> 710 +100 Q1 operating profit turned from a loss of 0.18 billion yen in the same period last year to a profit of 0.481 billion yen. Also announced dividend increase.
Stocks hitting the upper or lower price limit in the afternoon session.
Stop high: Aso Foam Crete (190A), Chordia Therapeutics (206A), PRISM Bio Lab (2173), Hakuten (2376), Cynex (2487), CDG (2754), Higashi Kashi Holdings (4286), CL Holdings (4444), Infonet (4492), Zenetec. Stop low: MAXIS US Treasury Bonds 20+ Year ETF (9823), Mami Mart. ※ Temporary stop.
Genetec: Financial report for the first quarter ending in March 2025.
Genetec: 1st quarter financial results for the March 2025 period (consolidated) based on Japanese standards.
Analysis
Price Target
No Data
No Data